Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | | | | | | | | -100.0% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | | | | | | | |
| Research and development | 15.2 | 22.3 | 17.2 | 8.3 | 1.0 | 2.3 | 4.9 | 4.8 |
| General and administrative | 9.3 | 9.4 | 5.8 | 5.8 | 4.0 | 2.8 | 3.6 | 2.6 |
| EBIT | -24.5 | -31.7 | -23.0 | -14.1 | -5.0 | -5.1 | -8.5 | -7.4 |
| EBIT margin | | | | | | | | |
| Pre-tax income | -24.5 | -31.8 | -23.3 | -13.9 | -5.0 | -5.0 | -8.5 | -9.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -24.5 | -31.8 | -23.3 | -13.9 | -5.0 | -5.0 | -8.5 | -9.2 |
| Net margin | | | | | | | | |
| |
| Diluted EPS | ($0.68) | ($1.07) | ($1.06) | ($0.70) | ($0.26) | ($0.27) | ($0.46) | ($0.68) |
| Shares outstanding (diluted) | 36.2 | 29.8 | 21.9 | 20.0 | 18.8 | 18.7 | 18.4 | 13.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|